Influences of TP53 expression on cellular radiation response and its relevance to diagnostic biodosimetry for mission environmental monitoring

Radiation Protection Dosimetry

Volumn 122, Issue 1-4, 2006, Pages 237-243

  Lu Hesselmann, J ^a   van Beuningen, D ^b   Meineke, V ^b   Franke, E ^a  

^a Bundeswehr Institute of Medical Occupational and Environmental Safety   (Germany)

^b Bundeswehr Institute of Radiobiology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA; PROTEIN P53; TP53 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL STRAIN HL 60; CONTROLLED STUDY; DNA DAMAGE; DOSIMETRY; EARLY DIAGNOSIS; ENVIRONMENTAL MONITORING; GENE TARGETING; GENETIC STABILITY; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IONIZING RADIATION; MOLECULAR MECHANICS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIATION INJURY; RADIATION MONITORING; RADIATION RESPONSE; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; STRESS; TRANSCRIPTION INITIATION; BIOASSAY; CELL PROLIFERATION; CELL SURVIVAL; METABOLISM; METHODOLOGY; RADIATION DOSE; RADIATION EXPOSURE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL ASSAY; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; HL-60 CELLS; HUMANS; RADIATION DOSAGE; RADIATION MONITORING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34347404328     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/rpd/ncl459     Document Type: Article

References (21)

1. Symonds H., Krall, L., Remington, L., Saenz Robles, M., Low, S., Jack, T. and Van Dyke, T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78, 703-711 (1994).
2. Siles, E., Villalobos, M., Valenzuela, M. T., Nunez, M. I., Gordon, A., McMillan, T. J., Pedraza, V. and Ruiz de Almodovar, J. M. Relationship between p53 status and radiosensitivity in human tumour cell lines. Br. J. Cancer 73, 581-588 (1996).
3. 2/M by p53. Oncogene 10, 109-115 (1995).
4. Rowan, S., Ludwig, R. L., Haupt, Y., Bates, S., Lu, X., Oren, M. and Vousden, K. H. Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J. 15, 827-838 (1996).
5. Lakin, N. D., Hann, B. C. and Jackson, S. P. The ataxia-telangiectasia related protein ATR mediates DNA-dependent phosphorylation of p53. Oncogene 18, 3989-3995 (1999).
6. Milner, J. Flexibility: The key to p53 function? Trends Biochem. Sci. 20, 49-51 (1995)
7. Wolf, D. and Rotter, V. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc. Natl Acad. Sci. USA. 82, 790-794 (1985).
8. Gilbertz, K. P., van Beuningen, D. and Rhein, A. P. Early changes in cell cycle kinetics after ionizing irradiation below 1 GY. Int. J. Radiat. Biol. 73, 187-195 (1998).
9. Reed, M., Woelker, B., Wang, P., Wang, Y., Anderson, M. E. and Tegtmeye, P. The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation, Proc. Natl Acad. Sci. USA 92 (1995) 9455-9459.
10. Bakalkin, G., Selivanova, G., Yakovleva, T., Kiseleva, E., Kashuba, E., Magnusson, K. P., Szekely, L., Klein, G., Terenius, L. and Wiman K. G. p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain, Nucleic Acids Res. 23 (1995) 362-369.
11. Kovach, J. S., Hartmann, A., Blaszyk, H., Cunningham, J., Schaid, D. and Sommer, S. S. Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value. Proc. Natl. Acad. Sci. USA 93, 1093-1096 (1996).
12. Sjogren, S., Inganas, M., Norberg, T., Lindgren, A., Nordgren, H., Holmberg, L. and Bergh, J. The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry. J. Natl Cancer Inst. 88, 173-182 (1996).
13. Hamada, M., Fujiwara, T., Hizuta, A., Gochi, A., Naomoto, Y., Takakura, N., Takahashi, K., Roth, J. A., Tanaka, N. and Orita, K. The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers. J. Cancer Res. Clin. Oncol. 122 360-365 (1996).
14. Biard, D. S., Martin, M., Rhun, Y. L., Duthu, A., Lefaix, J. L., May, E. and May, P. Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development. Cancer Res. 54, 3361-3364 (1994).
15. Okaichi, K., Wang, L. H. Ihara, M. and Okumura, Y. Sensitivity to ionizing radiation in Saos-2 cells transfected with mutant p53 genes depends on the mutation position. J. Radiat. Res. (Tokyo) 39, 111-118 (1998).
16. Pinyol, M., Hernandez, L., Martinez, A., Cobo, F., Hernandez, S., Bea, S. LopezGuillermo, A., Nayach, I., Palacin, A. and Campo, E. INK4a/ ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene. Am. J. Pathol. 156, 1987-1996 (2000).
17. INK4 Science 267, 249-252 (1995).
18. Sumitomo, K., Shimizu, E., Shinohara, A., Yokota, J. and Sone, S. Activation of RB tumor suppressor protein and growth suppression of small cell lung carcinoma cells by reintroduction of p16(INK4A) gene. Int. J. Oncol. 14, 1075-1080 (1999).
19. Schreiber, M., Muller, W. J., Singh, G. and Graham, F. L. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16(1NK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIPI) and p27(KIP1) in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity. Oncogene 18, 1663-1676 (1999).
20. Kastan, M. B., Canman, C. E. and Leonard, C. J. P53, cell cycle control and apoptosis: Implications for cancer. Cancer Metastasis Rev. 14, 3-15 (1995).
21. Harris, C. C. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies. J. Natl Cancer Inst. 88, 1442-1455 (1996).